Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Marek Health vs OrderlyMeds

Marek Health
Graded #173

Lower grade

vs+5.5
OrderlyMeds
Graded #78

Higher grade

The verdict

OrderlyMeds takes it — 72.4/100 to 66.9/100.

OrderlyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OrderlyMeds is a telehealth provider selling compounded semaglutide and tirzepatide with no membership fees or hidden costs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOrderlyMeds +47
45
92
Dose & formulationOrderlyMeds +24
40
64
Clinical oversightMarek Health +11
93
82
Labs & monitoringMarek Health +44
97
53
FulfillmentMarek Health +19
84
65
Contract termsEven
55
55
Marek Health · left barOrderlyMeds · right bar

The numbers

MetricMarek HealthOrderlyMeds
WeighScore66.9/10072.4/100
GradeCC
Scorecard rank#173#78
SemaglutideNot disclosed$74/mo (starting dose, 2-mo starter plan, new patients only, compounded)
TirzepatideNot disclosed$299/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Marek Health

Graded #173 · C

Strengths

  • Lab panels are core: initial comprehensive labs + 6–12 week follow-up + ongoing every 6 months — rare among GLP-1 providers
  • Dedicated Health Coach paired with each client alongside partnered licensed physician as standard Proactive Care Team
  • All 50 US states served; 100% telehealth with routine physician check-ins every 6 months built into the program
  • Human optimization framing attracts pragmatic patients; partnered physicians selected for data-driven, high-leverage mindset
  • No set subscription plan — custom protocol built around client health goals with option to cancel anytime

Where it loses points

  • Pricing fully gated — no published rates; intake assessment required before quotes, limiting upfront comparison shopping
  • Annual in-person physical required from own PCP or urgent care (every 12 months) — not provided by Marek Health
  • No LegitScript certification found; platform explicitly disclaims being a healthcare clinic, which reduces regulatory trust signals
  • Weight loss is one of many services alongside TRT, hair, brain focus, sexual health — not a dedicated GLP-1 platform
  • Compounded vs. brand medication details not disclosed publicly — medication type determined post-intake with partnered physician
OrderlyMeds

Graded #78 · C

Strengths

  • The starter rate and the standing rate are both published, so the step-up is visible before signing up
  • No membership fees and no hidden costs, stated as such
  • The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
  • Brand-name routes are priced openly, at retail

Where it loses points

  • The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
  • Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
  • Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard